Genome‐wide analysis of 270 B‐ALL cases and flow cytometry‐validated protein analysis of 135 B‐ALL cases revealed that half of them had higher CD86 expression than normal progenitor cells.53 This evidence concerns the gene CD86 and acute lymphoblastic leukemia.